The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...

The EU Court found the head of the European Commission, Ursula von der Leyen, responsible for concealing information about ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Patients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

European Court of Justice found that the Commission failed to explain why text messages with Pfizer should be kept from the ...

A top European court has ruled that the European Commission was wrong to refuse The New York Times access to text messages ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

The lack of transparency on European Commission President Ursula von der Leyen's Covid-era texts with the head of the ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...